Oxidative degradation of triclosan by potassium permanganate: Kinetics, degradation products, reaction mechanism, and toxicity evaluation

In this study, we systematically investigated the potential applicability of potassium permanganate for removal of triclosan (TCS) in water treatment. A series of kinetic experiments were carried out to study the influence of various factors, including the pH, oxidant doses, temperature, and presence of typical anions (Cl-, SO42-, NO3-), humic acid (HA), and fulvic acid (FA) on triclosan removal. The optimal reaction conditions were: pH = 8.0, [TCS](0):[KMnO4](0) = 1:2.5, and T = 25 degrees C, where 20 mg/L of TCS could be completely degraded in 120 s. However, the rate of TCS (20 mu g/L) oxidation by KMnO4 ([TCS](0):1KMnO(4)](0) = 1:2.5) was 1.64 x 10(-3) mg L-1 .h(-1), lower than that at an initial concentration of 20 mg/L (2.24 x 10(3) mg L-1.h(-1)). A total of eleven products were detected by liquid chromatography quadrupole -time-of-flight-mass spectrometry (LC-Q-TOF-MS) analysis, including phenol and its derivatives, benzoquinone, an organic acid, and aldehyde. Two main reaction pathways involving C-O bond cleavage (-C(8)-0(7)) and benzene ring opening (in the less chlorinated benzene ring) were proposed, and were further confirmed based on frontier electron density calculations and point charges. Furthermore, the changes in the toxicity of the reaction solution during TCS oxidation by KMnO4 were evaluated by using both the luminescent bacteria Photobacterium phosphoreum and the water flea Daphnia magna. The toxicity of 20 mg/L triclosan to D. magna and P. phosphoreum after 60 min was reduced by 95.2% and 43.0%, respectively. Phenol and 1,4-benzoquinone, the two representative degradation products formed during permanganate oxidation, would yield low concentrations of DBP5 (STHMFP, 20.99-278.97 mu g/mg; SHAAFP, 7.86 x 10(-4)-45.77 jig/mg) after chlorination and chloramination. Overall, KMnO4 can be used as an effective oxidizing agent for TCS removal in water and wastewater treatment. (C) 2016 Elsevier Ltd. All rights reserved.